The effect of derivatives of tetrahydropyrido[2,1-b][1,3,5] thiadiazine on hematologic indices of rats with subacute parotitis by Bybik, E. Y. et al.
The effect of derivatives of tetrahydropyrido[2,1-b]
[1,3,5] thiadiazine on hematologic indices of rats with 
subacute parotitis
Elena Y. Bybik1, Oksana G. Yaroshevskaya1, Andrey V. Demenko1, Konstantin A. Frolov1, 
Viktor V. Dotsenko2, Sergey G. Kryvokolysko1
1 Lugansk State Medcal University, 1g 50-letiya Oborony Luganska St, 91045 Lugansk, Russian Federation
2 Kuban State University, 149 Stavropol’skaya St., 350040 Krasnodar, Russian Federation
Corresponding author: Oksana G. Yaroshevskaya (korokina@bsu.edu.ru)
Academic editor: Oleg Gudyrev ♦ Received 11 July 2018 ♦ Accepted 13 July 2018 ♦ Published 10 August 2018
Citation: Bybik EY, Yaroshevskaya OG, Demenko AV, Frolov KA, Dotsenko VV, Kryvokolysko SG (2018) The effect of 
derivatives of tetrahydropyrido[2,1-b][1,3,5] thiadiazine on hematologic indices of rats with subacute parotitis. Research Result:  
Pharmacology and Clinical Pharmacology 4(2): 77–83. https://doi.org/10.3897/rrpharmacology.4.28305
Abstract
Introduction: Regardless of belonging of NSAIDs to one or another chemical group, they all have common side effects 
that can occur when using these drugs for a long or short period. One type of toxicity in the spectrum of side effects of 
modern non-steroidal anti-inflammatory drugs is hematotoxicity.
Objectives: to study the indices characterizing the red and white hematopoiesis in a clinical blood examination in 
animals with a simulated inflammation process against a background of pharmacocorrection with original thiadiazine 
derivatives.
Methods: The experiments were carried out on 48 white pedigree mature rats of both sexes weighing 170–210 g. The 
tetrahydropyrido [2,1-b] [1,3,5] thiadiazine derivatives II, III and V were selected, since they showed the strongest an-
ti-inflammatory, analgesic and antipyretic properties in the previous experiments. The animals were divided into eight 
groups: intact (rats without the pathology), control (with inlammation), referent 1 (inflammation+diclofenac sodium 
0.5 mg/kg), referent 2 (inflammation+analgin 5 mg/kg), referent 3 (inflammation+indomethacin 5 mg / kg) and three 
test groups (with test substances administered at a dose of 5 mg/kg). Administration of the drugs was carried out for 14 
days at the above doses. The standard methods were used to determine the number of erythrocytes, hemoglobin, color 
index, ESR, leukocytes and neutrophils.
Results: In the analysis of the numerical results of the experiment, the valid ranges of values were determined for 
most parameters under study, which made it possible to use nonparametric statistical methods, including the Wilcoxon 
signed-rank test, to evaluate the reliability of differences. The use of tetrahydropyrido [2,1-b] [1,3,5] thiadiazine deriv-
atives II, III, V in animals with experimental parotitis was accompanied by an increase in the number of erythrocytes in 
comparison with that in the control group.
Conclusion: The studies of three derivatives of tetrahydropyrido [2.1-b] [1.3.5] thiadiazine, which have a high anti-in-
flammatory activity, proved that the compounds III and V have no hematotoxicity.
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Introduction
Historically, anti-inflammatory drugs have their origin in 
the happy discovery of certain plants, and their extracts 
are used to relieve pain, fever and inflammation. When 
salicylates were discovered in the mid-19th century to be-
come the active components of willow SPP, this enabled 
these compounds to be synthesized from this; acetyl-sali-
cylic acid or trademark aspirin was developed (Rainsford 
2007). Nonsteroidal anti-inflammatory drugs (NSAIDs), 
which act by inhibiting cyclooxygenase (COX) isoenzy-
mes, was discovered over 100 years ago. They remain a 
key component of the pharmacological treatment of acu-
te and chronic pain. COX-1 and COX-2 isozymes have 
different biological functions; analgesic activity is prima-
rily (though not exclusively) associated with inhibition 
of COX-2, with the various side effects resulting from 
inhibition of COX-1 and COX-2 (Brune and Patrignani 
2015). More recently, a spinal site of cyclooxygenase 
activity relevant to pain has been proposed. In animals, 
prostaglandins are synthesized in the spinal cord (Eisen-
ach et al.  2010). Currently, in the arsenal of a doctor there 
is a wide range of drugs that can block the development 
of an inflammatory reaction. They include non-steroid 
anti-inflammatory drugs, glucocorticoids (GC), anti-cyto-
kinic drugs as well as Symptomatic Slow Acting Drugs 
for Osteoarthritis (SYSADOA, previously referred to 
as ”chondroprotectors”). Furthermore, there are various 
drugs for the “point” exposure on individual inflammato-
ry mediators being developed and in the stage of clinical 
approbation (Karateev et al. 2017). In particular, the po-
tential for gastrointestinal toxicity with traditional non-
selective NSAIDs may be a significant limitation to their 
use. Gastrointestinal bleeding, ulceration and perforation 
are the most common serious adverse events associated 
with NSAIDs and often lead to the cessation of NSAID 
therapy and expensive treatment for gastropathic symp-
toms themselves (Collantes et al. 2002, Karateev et al. 
2015). Currently, a long list of the approved anti-inflam-
matory drugs contains a very small number of high-per-
formance samples with a minimum of side effects with 
their long-term use (Karateev et al. 2015, Smolen et al. 
2016, Nasonov 2015, Clauw 2015). Therefore, the search 
for new and safe means of pharmacotherapy for inflam-
matory diseases is an urgent task of modern pharmacolo-
gical research (Kroon et al. 2015).
One of the promising directions of this research may be 
a complex study of partially hydrogenated 1,3,5-thiadia-
zines, which have a wide spectrum of pharmacodynamic 
activity (Dotsenko et al. 2015). The screening studies of 
the new tetrahydropyrido [2,1-b] [1,3,5] thiadiazine de-
rivatives (Dotsenko et al. 2014, Osolodkin et al. 2013) 
showed that compounds I, II have the most evident analge-
sic activity. A number of substances showed a high analge-
sic activity, exceeding that of analgin (Bybik et al. 2016). 
In addition, on the “formalin paw edema” model, the 
compounds with evident anti-inflammatory activity were 
found among the test samples. Compounds III-IV (Fig. 1) 
showed the best results, exceeding the sodium diclofenac 
3.5 and 2.13 times, respectively (Bybik et al. 2016).
Studies of the acute toxicity of tetrahydropyrido [2,1-
b] [1,3,5] thiadiazine derivatives with intraperitoneal sin-
gle administration to rats by V.B.Prozorovsky’s method 
at an ascending dose showed that the samples II, III and 
V (Fig. Formulas of test substances) referred to toxicity 
class 3 (moderately toxic compounds), the LD
50
 value for 
them was 450±35 mg/kg (Belous 2005).
Objectives 
In connection with this, the objective of this experiment was 
to study the indices characterizing the red and white hema-
topoiesis in a clinical blood examination in animals with 
a simulated inflammation process against a background of 
pharmacocorrection with original thiadiazine derivatives.
Materials and methods 
The present pharmacological experiments were carried 
out on 48 white pedigree mature rats of both sexes weig-
hing 170–210 g in the autumn in a certified pharmacolo-
gical laboratory. The animals throughout the experiment 
period were kept in vivarium conditions on a standard 
diet, with no more than six individuals in a cage in accor-
dance with the rules for working with laboratory animals. 
The conditions of keeping animals and the manipulations 
carried out with them were in compliance with the re-
quirements from the the guidelines for the ethical review 
of biomedical research (Habriev 2005). Before the be-
ginning of the experiment, all the animals were carefully 
examined, considering their weight, age, motor activity 
and condition of hair.
In the experiment, there were used the minimum num-
ber of animals (6 in the group) acceptable for statistical 
processing and getting reliable results, and the minimum 
number of experimental groups, to achieve the goal and 
to solvr the research problems, i.e the total number of 
animals.
Figure 1. Formulas of test substances. I: R1 = 3,4,5-(MeO)3C6H2, 
R2 = Bn; II: 2-MeOC6H4, 2-EtC6H4; III: 2-MeOC6H4, 3-Cl-
4-MeC6H3; IV: 3,4,5-(MeO)3C6H2, 2-FurCH2; V: 3-MeO-4-
EtOC6H3, 4-ClC6H4.
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As an experimental model of inflammation, a patho-
logical process that develops in animals after a single in-
jection of a formalin solution (1%-0.2 ml) into the region 
of the right retromandibular fossa – the projection of the 
parotid salivary gland – was used. For the experiments, 
the tetrahydropyrido [2,1-b] [1,3,5] thiadiazine deriva-
tives II, III and V were selected, since they showed the 
strongest anti-inflammatory, analgesic and antipyretic 
properties in the previous experiments.
After external examination and rejection, the rats were 
divided into eight groups: intact (rats without patholo-
gy), control (inflammation), referent 1 (inflammation+di-
clofenac sodium 0.5 mg/kg), referent 2 (inflammation+an-
algin 5 mg/kg) , referent 3 (inflammation+indomethacin 5 
mg/kg), experiment 1 (inflammation+ТD0330 5 mg/kg), 
experiment 2 (inflammation+ТD0470 5 mg/kg), exper-
iment 3 (inflammation+ТD0472 5 mg/kg). The admin-
istration of the drugs was carried out for 14 days at the 
above doses. After the end of the experiment, blood was 
taken from the femoral vein. The standard methods were 
used to determine the number of erythrocytes, hemoglo-
bin, color index, ESR, leukocytes and neutrophils.
The statistical processing of the data was carried out us-
ing the software package Statistica. In connection with the 
use of a small number of experimental specimens in the ex-
periment, an analysis of the experimental data in respect of 
normality of distribution indicated an insufficient sample 
size for obtaining significant differences in the processing 
of data by classical parametric methods. With further anal-
ysis of the numerical results of the experiment, valid rang-
es of values for most of the indicators were determined, 
which allowed using nonparametric statistical methods, 
including the Wilcoxon signed-rank test (Kobzar’ 2006).
Results and discussion
As we can see from Fig. 2 and Table 1 of the data, the 
number of erythrocytes in the blood of the animals in the 
control group with subacute parotitis significantly decre-
ased (p<0.03) by 16.8% compared to the values recorded 
in the intact group. In reference groups 1, 2 and 3, no sig-
nificant differences were found. 
The use of tetrahydropyrido [2,1-b] [1,3,5] thiadiazine 
derivatives II, III, and V in animals with experimental 
mumps was accompanied by a significant increase in the 
number of erythrocytes in comparison with the control 
group. Thus, the administration of compound V result-
ed in the restoration of and administration of compound 
III promoted an increase in the number of erythrocytes 
in rats with experimentally modeled parotitis to the level 
of the intact animals (Fig. 2). The data of the conducted 
experimental studies concerning the hemoglobin level in 
the blood of the rats of the control group showed a sharp 
significant decrease (by 16.3%) in comparison with the 
indicator registered in the intact group (Fig. 3, Table 1).
The referents used do not have the same effect on the 
red blood-germ cells. From Fig. 2 we can see, that a 14-
day application of indomethacin in the animals with ex-
perimental parotitis resulted in a significant decrease in 
the amount of hemoglobin in the blood by 21.4% com-
pared to the indicator in the intact group of animals.
The condensed derivatives of thiadiazine III and 
V used in the experimental groups were able to restore the 
hemoglobin index against the background of the simulat-
ed inflammatory process of the parotid salivary gland to 
the normal values (Table 1). 
The values of the color index shown in Fig. 4 and in 
Table 1, show a significant (p<0.03) decrease in the value 
of this parameter in the control group of rats in compari-
son with the intact group similar to that found in the rats 
in reference groups 2 and 3, which received analgin and 
indamethacin as a treatment for subacute parotits. In the 
animals of experimental groups receiving samples III and 
V, significant differences in the colour index were found 
from the parameters in the control group.
As can be seen from Fig. 5, the erythrocyte sedimen-
tation rate increases 4-fold in the group of laboratory ani-
Figure 2. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg and indomethacin 5 mg/kg per the number of erythrocytes in the 
blood of the rats studied groups after treatment for subacute parotits
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Table 1. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg and indomethacin 5 mg/kg on the index of the clinical analysis of 
blood of the rats in the groups under study
Group of 
animals
Number of 
erythrocytes
Hemoglobin Colour index Erythrocyte 
sedimentation rate
Number of leukocytes
Intact 6.82±0.31 154.67±9.63 0.74±0.03 1.67±0.82 6.92±1.72
p<0.05 p<0.05 p<0.05 p<0.05 p<0.1
Control 5.68±0.31 129.00±5.80 0.58±0.03 6.67±1.63 5.08±0.64
Diclophenac 5.50±1.57 143.3±14.01 0.59±0.03 1.83±1.33 9.12±0.45
p>0.5 p<0.05 p<0.05 p<0.05 p<0.05
Analgin 5.70±0.45 148.33±4.27 0.57±0.03 2.00±1.10 4.03±0.14
p>0.5 p<0.05 p<0.6 p<0.05 p<0.05
Indomethacin 5.35±0.25 121.67±5.16 0.66±0.03 1.83±0.75 3.32±0.31
p<0.1 p<0.1 p<0.6 p<0.05 p<0.05
II 6.38±1.08 148.00±17.3 0.71±0.03 2.17±1.17 5.65±2.19
p<0.5 p<0.6 p<0.5 p<0.05 p<0.6
III 7.18±0.44 168.83±5.34 0.77±0.11 1.67±1.21 7.55±1.45
p<0.05 p<0.05 p<0.05 p<0.05 p<0.05
V 6.97±0.14 165.17±5.15 0.66±0.13 1.33±0.52 4.88±0.17
p<0.0277 p<0.05 p<0.05 p<0.05 p<0.5
р – is calculated in relation to the control.
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Figure 3. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg, indomethacin 5 mg/kg and the test substances on the amount of 
hemoglobin in the blood of the rats of the groups under study after treatment for subacute parotits
mals with experimental parotits (control). In all reference 
groups and in all experimental groups, there are signifi-
cant differences in comparison with the control.
Comparing the values of leukocytes in the blood of 
the rats with a simulated inflammatory process with 
those of the intact animals (Table 1), a decrease of 
26.6% can be seen. The reference medications, which 
were used, showed heterogeneity of their action with to-
wards white blood cell lineage of the rats with subacute 
parotits. Thus, the administration of diclofenac sodium 
leads to a significant increase in the number of leuko-
cytes under the experimental conditions, whereas the 
use of analgin in the animals with inflammation of the 
parotid salivary gland can reduce the leukocyte count by 
41.85% in comparison with the intact group. An even 
more pronounced depression of white blood cell lineage 
growth was found in reference group 3 (indomethacin). 
There was a decrease of 52% there in comparison with 
the intact group and of 34.5% in comparison with the 
control group.
Comparing the total number of leukocytes in the 
blood of the rats receiving substance V with the anal-
ogous values of the rats of the control group, no signif-
icant differences were revealed (Fig 6, Table 1). In the 
experimental group of the rats receiving substance III, 
the total number of leukocytes exceeded the control by 
48.6% and had a comparable value with that of the ani-
mals of the intact group. 
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Figure 4. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg, indomethacin 5 mg/kg and test substances on сolour index of the 
blood of the rats of the study groups, after treatment for subacute parotits
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Figure 5. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg, indomethacin 5 mg/kg and test substances on the sedimentation rate 
of erythrocytes in the blood of the rats of the study groups, after treatment for subacute parotits
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Figure 6. The effect of diclofenac 0.5 mg/kg, analgin 5 mg/kg, indomethacin 5 mg/kg and test substances on the total number of 
leukocytes in the blood of the rats of the study groups, after treatment for subacute parotits 
Research Result: Pharmacology and Clinical Pharmacology 4(2): 7–83    7
Bybik EY et al.: The effect of  derivatives of  tetrahydropyrido ...82
Conclusion
Thus, the results obtained confirm the data about a high 
hematotoxicity of indamethacin and analgin. The stud-
ies of three tetrahydropyrido [2,1-b] [1,3,5] thiadiazine 
derivatives with high anti-inflammatory activity identi-
fied compounds III (3-(3-chloro-4-methylphenyl)-8-(2-
methoxyphenyl)-6-oxo-3,4,7,8-tetrahydro-2H, 6H-pyr-
ido [2,1-b] [1,3,5]-thiadiazine-9-carbonitrile) and V 
(3-(4-chlorophenyl)-8-(4-ethoxy-3-methoxyphenyl)-6-
oxo-3,4,7,8-tetrahydro-2H, 6H-pyrido [2,1-b] [1,3,5] thia-
diazine-9-carbonitrile) as not showing hematotoxicity. 
The question of the mechanisms of action of these 
drugs remains open. In the future, a promising direction 
of research is looking for points of application of these 
tetrahydropyrido [2,1-b] [1,3,5] thiadiazine derivatives.
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